Both in Pharmaceuticals
Rein Therapeutics vs Oncolytics Biotech
Over the past year RNTX returned −57.2% and ONCY returned −64.3%; their daily moves had a correlation of 0.09.
RNTX −57.2% ONCY −64.3%Growth of $1, one year, split-adjusted
| Metric | RNTX | ONCY |
|---|---|---|
| Price | $0.6700 | $0.4254 |
| Market cap | $57.8M | $55.8M |
| Today | −7.79% | −0.54% |
| 1 month | −21.4% | −33.7% |
| 6 months | −35.0% | −51.1% |
| Year to date | −42.2% | −51.3% |
| 1 year | −56.8% | −63.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $40.6M | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 95.3% | 63.7% |
| Short % of float | 2.6% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).